65--NOTICE OF INTENT TO SOLE SOURCE REAGENTS FOR ILLUMINA MISEQ DNA SEQUENCING SYSTEM

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of Walter Reed Army Research Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with Illumina, Inc, 5200 Illumina Way, San Diego, CA 92122, a firm-fixed price Requirements Indefinite Delivery contract for the procurement of Reagent Panels that support the Illumina MiSeq DNA Sequencing System. Specifically, the government will purchase the following for the purpose of supporting global surveillance capabilities in preparation for potential pandemic outbreak of H7N9 and/or novel Middle East Coronavirus. MS-102-2003 MiSeq Reagent kit v2 (250 cycles) MS-102-3003 MiSeq Reagent kit v3 (600 cycle) FC-121-3001 TruSeq DNA PCR-Free Prep Kit Set A FC-121-3002 TruSeq DNA PCR-Free Prep Kit Set B FC-121-3003 TruSeq DNA PCR-Free Prep Kit Set, Samples FC-132-1001 Mate Pair Kit SV-420-1007 Advantage Service Contract These funds are obligated only upon the issuance of delivery orders. The contract will include a one-year base period with four one-year option periods. The North American Industry Classification System (NAICS) for this requirement is 325413 and the size standard is 500 employees. This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Dawn Jennings at [email protected]. NO TELEPHONE REQUESTS WILL BE HONORED. Interested concerns must identify their capability in writing to the above e-mail address no later than 4:00 pm EST, September 22, 2014. All email correspondence should reference quote mark Reagents/ Illumina MiSeq DNA Sequencing System quote mark in the subject line.